Drug-eluting stents: do the risks really outweigh the benefits?

Austin, D., Pell, J. and Oldroyd, K.G. (2008) Drug-eluting stents: do the risks really outweigh the benefits? Heart, 94(2), pp. 127-128. (doi:10.1136/hrt.2007.123141)

Full text not currently available from Enlighten.

Abstract

The safety of drug-eluting stents (DES) has been called into question by studies suggesting a predisposition to late stent thrombosis—an uncommon but potentially fatal complication.1–4 Consequently, balancing the risks and benefits of DES use in an individual patient undergoing percutaneous coronary intervention (PCI) is challenging, particularly as studies have often been unrepresentative of routine practice, underpowered, prone to bias or used inconsistent definitions of stent thrombosis.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Pell, Professor Jill
Authors: Austin, D., Pell, J., and Oldroyd, K.G.
College/School:College of Medical Veterinary and Life Sciences > Institute of Health and Wellbeing > Public Health
College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing > Centre for Population and Health Sciences
Journal Name:Heart
Publisher:BMJ Publishing Group
ISSN:1355-6037
ISSN (Online):1468-201X

University Staff: Request a correction | Enlighten Editors: Update this record